Ethnobotanical and anti-diabetic properties of Rydingia persica (Burm.f.) Scheen & V.A.Albert: A comprehensive review

Document Type : Review Article

Authors

Department of Phytopharmaceuticals (Traditional Pharmacy), School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran

10.30476/tips.2025.105864.1284

Abstract

Rydingia persica (Burm.f.) Scheen & V.A.Albert is an endemic plant known for its use in Iranian folk medicine. The decoction made from the roots and aerial parts of R. persica has been traditionally utilized for its anti-diabetic properties in Iran. This study aims to highlight the ethnomedicinal, pharmacological, and anti-diabetic activities of R. persica. The review encompasses clinical, in vivo, and in vitro studies related to diabetes and its complications. A comprehensive literature search was conducted across various scientific databases, including PubMed, Scopus, ISI-Web of Science, and the local Iranian database IRANDOC. Relevant articles were identified using keywords "Rydingia persica," "Otostegia persica," "ShekarShafa," "Goldar/Golder," and "Gol-Khaarou," covering studies published from the inception up to 2024. Pharmacological studies on R. persica indicate significant anti-diabetic potential. Various extracts from the plant, especially its aerial parts, have demonstrated anti-hyperglycemic, anti-hyperlipidemic, and antioxidant effects in both in vitro and in vivo studies. Key phytochemicals, including quercetin, caffeic acid, and isorhamnetin have been identified as major contributors to these effects. The extracts of the plant have shown promising results in lowering blood glucose levels, improving insulin sensitivity, and reducing oxidative stress. Furthermore, R. persica has demonstrated protective effects on vital organs, including the liver and kidneys, in animal models. Despite these encouraging findings, clinical studies involving human participants remain limited. Only one trial has reported insignificant effects from a methanol extract of the leaves. Therefore, further research, particularly clinical trials, is needed to validate the therapeutic potential of R. persica for managing diabetes.

Highlights

Ghazaleh Mosleh (Google Scholar)

Abdolali Mohagheghzadeh (Google Scholar)

Keywords

References

1.    Watkins PJ. What is diabetes? In: ABC of Diabetes. 5th ed. London: BMJ Books; 2002. p. 1-6.
2.    Zaccardi F, Webb DR, Yates T, Davies MJ. Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective. Postgrad Med J. 2016 Feb;92(1084):63-9. doi: 10.1136/postgradmedj-2015-133281. Epub 2015 Nov 30. PMID: 26621825.
3.    Jia Q, Zhu R, Tian Y, Chen B, Li R, Li L, et al. Salvia miltiorrhiza in diabetes: A review of its pharmacology, phytochemistry, and safety. Phytomedicine. 2019 May;58:152871. doi: 10.1016/j.phymed.2019.152871. Epub 2019 Feb 18. PMID: 30851580.
4.    Asgarpanah J, Mohammadi Motamed S. A review on phytochemistry and pharmacology of Otostegia persica (Burm.f.) Boiss. J Med Plants. 2013;12(47):8-18.
5.    Sadeghi Z, Akaberi M, Valizadeh J. Otostegia persica (Lamiaceae): A review on its ethnopharmacology, phytochemistry, and pharmacology. Avicenna J Phytomed. 2014;4(2):79-88.
6.    Ayatollahi SA, Kobarfard F, Asgarpanah J, Rahmati Roodsari M, Fanai G, Iqbal Choudhary M. Diterpenoids of Otostegia persica (Burm.) Boiss. Daru. 2009;17(4):290-3.
7.    Zargari A. Medicinal plants. Tehran University Press, Iran, 1989. 
8.    Sadeghi Z, Kuhestani K, Abdollahi V, Mahmood A. Ethnopharmacological studies of indigenous medicinal plants of Saravan region, Baluchistan, Iran. J Ethnopharmacol. 2014 Apr 11;153(1):111-8. doi: 10.1016/j.jep.2014.01.007. Epub 2014 Feb 5. PMID: 24509152.
9.    Kosari M, Salami M. Investigation of antioxidant, antibacterial, and medicinal properties of the Golder plant. In: National Conference on Medicinal, Aromatic, and Spice Plants; 2016:1-27. Available from: https://sid.ir/paper/884058/fa
10.    Sadeghi Z. Phytochemical study and antimicrobial properties of two medicinal plants, Otostegia persica and Otostegia aucheri, from Saravan region [Thesis]. University of Sistan and Baluchestan - Faculty of Sciences; 2009:24-25.
11.    Keshavarz I. Evaluation of the inhibitory effect of some plant extracts on α-amylase enzyme activity (in vitro) and determination of the hypoglycemic property of the most effective extract (in vivo) [Thesis]. Kerman: Faculty of Sciences, Shahid Bahonar University of Kerman; 2013.
12.    Dolatkhahi M, Dolatkhahi A, Nejad JB. Ethnobotanical study of medicinal plants used in Arjan - Parishan protected area in Fars Province of Iran. Avicenna J Phytomed. 2014 Nov;4(6):402-12. PMID: 25386404; PMCID: PMC4224954.
13.    Dourandishan M, Hossieni M, Malekaneh M, Bagherzade G. Effect of Otostegia persica’s root extract on the blood biochemical factors in diabetic hyperlipidemic rats. Intern Med Today 2014; 20 (1) :17-21
14.    Lum Nde A, Chukwuma CI, Erukainure OL, Chukwuma MS, Matsabisa MG. Ethnobotanical, phytochemical, toxicology and anti-diabetic potential of Senna occidentalis (L.) link; A review. J Ethnopharmacol. 2022 Jan 30;283:114663. doi: 10.1016/j.jep.2021.114663. Epub 2021 Sep 21. PMID: 34560215.
15.    Moein S, Jahanshai S, Rahimzadeh M, Moein. Kinetic of α-amylase and comparison its inhibition by ethanol and aqueous extracts of Otostegia persica, Salvia mirzayanii and Zataria multiflora. Iran J Sci Technol Trans A Sci. 2018;42(2):339-45.
16.    Rouzbehan S, Moein S, Homaei A, Moein MR. Kinetics of α-glucosidase inhibition by different fractions of three species of Labiatae extracts: a new diabetes treatment model. Pharm Biol. 2017 Dec;55(1):1483-1488. doi: 10.1080/13880209.2017.1306569. PMID: 28367665; PMCID: PMC7011978. 
17.    Ayatollahi SAM, Kobarfard F, Asgarpanah J, Choudhary MI. Antiglycation activity of Otostegia persica (Burm.) Boiss. Afr J Biotechnol. 2010;9(24):3645-8.
18.    Dhanya R, Arya AD, Nisha P, Jayamurthy P. Quercetin, a Lead Compound against Type 2 Diabetes Ameliorates Glucose Uptake via AMPK Pathway in Skeletal Muscle Cell Line. Front Pharmacol. 2017 Jun 8;8:336. doi: 10.3389/fphar.2017.00336. PMID: 28642704; PMCID: PMC5462925.
19.    Zhuang M, Qiu H, Li P, Hu L, Wang Y, Rao L. Islet protection and amelioration of type 2 diabetes mellitus by treatment with quercetin from the flowers of Edgeworthia gardneri. Drug Des Devel Ther. 2018 Apr 23;12:955-966. doi: 10.2147/DDDT.S153898. PMID: 29720871; PMCID: PMC5918626.
20.    Paoli P, Cirri P, Caselli A, Ranaldi F, Bruschi G, Santi A, et al. The insulin-mimetic effect of Morin: A promising molecule in diabetes treatment. Biochim Biophys Acta. 2013;1830(4):3102-11.
21.    Akbarzadeh S. Anti-diabetic effect of Otostegia persica extract on diabetic rats. J Med Plant Res. 2012;6(16).
22.    Ebrahimpoor-Mashhadi MR, Khaksar Z, Noorafshan A, Mogheisi B. Stereological study of the effects of orally administrated Otostegia persica extract on pancreatic beta cells in male diabetic rats. Comp Clin Pathol. 2014;23(3):523-525.
23.    Hedayati M, Pouraboli I, Pouraboli B, Dabiri S, Javadi A. Effects of Otostegia persica extract on serum level of glucose and morphology of pancreas in diabetic rats. Koomesh J. 2012;13(2):201-8.
24.    Rezaian M, Dilmaghanian A, Shomali T, Adibmoradi M, Rassouli A. Bone protective effects following ethanolic extract (Otostegia persica) administration in streptozotocin-induced diabetic rats: Histomorphometric study. J Vet Res. 2015;70(1):109-18.
25.    Rezaian M, Shomali T, Dilmaghanian A, Rassouli A. Ethanolic extract of Otostegia persica ameliorates bone loss in diabetic rats irrespective to its glucose lowering effect. Comp Clin Pathol. 2014;23(5):1147-51.
26.    Hossain CM, Ghosh MK, Satapathy BS, Dey NS, Mukherjee B. Apigenin causes biochemical modulation, GLUT4 and CD38 alterations to improve diabetes and to protect damages of some vital organs in experimental diabetes. Am J Pharmacol Toxicol. 2014;9(1):39-52.
27.    Yusuf M, Nasiruddin M, Sultana N, Badruddeen, Akhtar J, Khan MI, et al. Regulatory mechanism of caffeic acid on glucose metabolism in diabetes. Res J Pharm Technol. 2019;12(10):4735-40.
28.    Matboli M, Saad M, Hasanin AH, A Saleh L, Baher W, Bekhet MM, et al. New insight into the role of isorhamnetin as a regulator of insulin signaling pathway in type 2 diabetes mellitus rat model: Molecular and computational approach. Biomed Pharmacother. 2021 Mar;135:111176. doi: 10.1016/j.biopha.2020.111176. Epub 2021 Jan 2. PMID: 33401224.
29.    Hussein J, Zakaria ZE, Latif YA, Khateeb S. Quercetin ameliorates endothelial dysfunction and prevents elevation of asymmetrical dimethylarginine in experimental diabetes. Der Pharma Chemica. 2016;8(13):247-52.
30.    Nuraliev IuN, Avezov GA. Effektivnost' kvertsetina pri alloksanovom diabete [The efficacy of quercetin in alloxan diabetes]. Eksp Klin Farmakol. 1992 Jan-Feb;55(1):42-4. Russian. PMID: 1305433.
31.    Oyedemi SO, Nwaogu G, Chukwuma CI, Adeyemi OT, Matsabisa MG, Swain SS, et al. Quercetin modulates hyperglycemia by improving the pancreatic antioxidant status and enzymes activities linked with glucose metabolism in type 2 diabetes model of rats: In silico studies of molecular interaction of quercetin with hexokinase and catalase. J Food Biochem. 2020 Feb;44(2):e13127. doi: 10.1111/jfbc.13127. Epub 2019 Dec 26. PMID: 31876980.
32.    Dokumacioglu E, Iskender H, Sen TM, Ince I, Dokumacioglu A, Kanbay Y, et al. The Effects of Hesperidin and Quercetin on Serum Tumor Necrosis Factor-Alpha and Interleukin-6 Levels in Streptozotocin-induced Diabetes Model. Pharmacogn Mag. 2018 Apr-Jun;14(54):167-173. doi: 10.4103/pm.pm_41_17. Epub 2018 Apr 10. PMID: 29720826; PMCID: PMC5909310.
33.    Ataabadi G, Shahinfar N, Mardani G, Gholami M. Effect of Otostegia persica extract on blood glucose in patients with type II diabetes. J Pharm Negat Results. 2019;10(1):52-6.
34.    Safaeian L, Yaghoobi S, Javanmard SH, Ghasemi-Dehkordi N. The effect of hydroalcoholic extract of Otostegia persica (Burm.) Boiss. against H2O2-induced oxidative stress in human endothelial cells. Res J Pharmacogn. 2017;4(1):51-8.
35.    Sharififar F, Mozaffarian V, Moradkhani S. Comparison of antioxidant and free radical scavenging activities of the essential oils from flowers and fruits of Otostegia persica Boiss. Pak J Biol Sci. 2007 Nov 1;10(21):3895-9. doi: 10.3923/pjbs.2007.3895.3899. PMID: 19090249.
36.    Yassa N, Sharififar F, Shafiee A. Otostegia persica as a source of natural antioxidants. Pharm Biol. 2005;43(1):33-8.
37.    Nasiri Bezenjani S, Pouraboli I, Malekpour Afshar R, Mohammadi G. Hepatoprotective Effect of Otostegia persica Boiss. Shoot Extract on Carbon Tetrachloride-Induced Acute Liver Damage in Rats. Iran J Pharm Res. 2012 Fall;11(4):1235-41. PMID: 24250558; PMCID: PMC3813173.
38.    Takhtfooladi MA, Takhtfooladi HA, Moayer F, Karimi P, Asl HA. Effect of Otostegia persica extraction on renal injury induced by hindlimb ischemia-reperfusion: a rat model. Int J Surg. 2015 Jan;13:124-130. doi: 10.1016/j.ijsu.2014.11.047. Epub 2014 Dec 6. PMID: 25486262.
39.    Safaeian L, Ghasemi-Dehkordi N, Javanmard ShH, Namvar H. Antihypertensive and antioxidant effects of a hydroalcoholic extract obtained from aerial parts of Otostegia persica (Burm.) Boiss. Res Pharm Sci. 2015 May-Jun;10(3):192-9. PMID: 26600845; PMCID: PMC4621625.
40.    Oršolić N, Sirovina D, Odeh D, Gajski G, Balta V, Šver L, et al. Efficacy of Caffeic Acid on Diabetes and Its Complications in the Mouse. Molecules. 2021 May 28;26(11):3262. doi: 10.3390/molecules26113262. PMID: 34071554; PMCID: PMC8199327.
41.    Deepa B, Anuradha CV. Linalool, a plant derived monoterpene alcohol, rescues kidney from diabetes-induced nephropathic changes via blood glucose reduction. Diabetol Croat. 2011;40(4):121-37.
42.    Sharma P, Aggarwal K, Awasthi R, Kulkarni GT, Sharma B. Behavioral and biochemical investigations to explore the efficacy of quercetin and folacin in experimental diabetes induced vascular endothelium dysfunction and associated dementia in rats. J Basic Clin Physiol Pharmacol. 2021 Jun 21;34(5):603-615. doi: 10.1515/jbcpp-2020-0159. PMID: 34161695.
43.    Manzari-Tavakoli A, Pouraboli I, Yaghoobi MM, Mehrabani M, Mirtadzadini SM. Antihyperglycemic, antilipid peroxidation, and insulin secretory activities of Otostegia persica shoot extract in streptozotocin-induced diabetic rats and in vitro C187 pancreatic β-cells. Pharm Biol. 2013 Feb;51(2):253-9. doi: 10.3109/13880209.2012.718351. Epub 2012 Nov 7. PMID: 23134106.
44.    Mao XY, Yu J, Liu ZQ, Zhou HH. Apigenin attenuates diabetes-associated cognitive decline in rats via suppressing oxidative stress and nitric oxide synthase pathway. Int J Clin Exp Med. 2015 Sep 15;8(9):15506-13. PMID: 26629041; PMCID: PMC4658930.
45.    Xu W, Luo Q, Wen X, Xiao M, Mei Q. Antioxidant and anti-diabetic effects of caffeic acid in a rat model of diabetes. Trop J Pharm Res. 2020;19(6):1227-32.
46.    Gorbenko NI, Borikov OY, Ivanova OV, Taran EV, Litvinova TS, Kiprych TV, et al. The effect of quercetin on oxidative stress markers and mitochondrial permeability transition in the heart of rats with type 2 diabetes. Ukr Biochem J. 2019;91(5):46-54.
47.    Margina D, Gradinaru D, Manda G, Neagoe I, Ilie M. Membranar effects exerted in vitro by polyphenols - quercetin, epigallocatechin gallate and curcumin - on HUVEC and Jurkat cells, relevant for diabetes mellitus. Food Chem Toxicol. 2013 Nov;61:86-93. doi: 10.1016/j.fct.2013.02.046. Epub 2013 Mar 4. PMID: 23466460.
48.    Mahmoud MF, Hassan NA, El Bassossy HM, Fahmy A. Quercetin protects against diabetes-induced exaggerated vasoconstriction in rats: effect on low grade inflammation. PLoS One. 2013 May 22;8(5):e63784. doi: 10.1371/journal.pone.0063784. PMID: 23717483; PMCID: PMC3661670.
49.    Ravikumar N, Kavitha CN. Immunomodulatory effect of quercetin on dysregulated Th1/Th2 cytokine balance in mice with both type 1 diabetes and allergic asthma. J Appl Pharm Sci. 2020;10(3):80-7.
50.    Hedayati M, Pouraboli I, Pouraboli B. Effect of methanolic extract of Otostegia persica on serum levels of glucose and lipids in type I diabetic male rats. Iran J Endocrinol Metab. 2010;12(4):435-58.
51.    Tahmasebi A, Jamali B, Atabaki V, Sarker SD, Nahar L, Min HJ, et al. A comprehensive review of the botany, ethnopharmacology, phytochemistry, and pharmacological activities of two Iranian Rydingia species (Lamiaceae). Fitoterapia. 2024 Jul;176:106026.
52.    Bagherzade G, Dourandishan M, Malekaneh M. Antidiabetic effects of Otostegia persica root in alloxan-induced diabetic rats. Pure Appl Chem Sci. 2014;2:1-9.
53.    Liu Y, Liu S, Wang H, Su W. Protective effect of caffeic acid on streptozotocin induced gestational diabetes mellitus in rats: Possible mechanism. Pakistan J Zool. 2021;53(3):1045-52.
54.    Parvin A, Yaghmaei P, Noureddini M, Haeri Roohani SA, Aminzadeh S. Comparative effects of quercetin and hydroalcoholic extract of Otostegia persica boiss with atorvastatin on atherosclerosis complication in male wistar rats. Food Sci Nutr. 2019 Aug 16;7(9):2875-2887. doi: 10.1002/fsn3.1136. PMID: 31572581; PMCID: PMC6766565.
55.    Lontchi-Yimagou E, Sobngwi E, Matsha TE, Kengne AP. Diabetes mellitus and inflammation. Curr Diab Rep. 2013 Jun;13(3):435-44. doi: 10.1007/s11892-013-0375-y. PMID: 23494755.
56.    Takhtfooladi MA, Asghari A, Hoseinzadeh HA, Mokhtari F. Effect of Otostegia persica extract on ischemia/reperfusion induced renal damage in diabetic rats. A biochemical study. Acta Cir Bras. 2016;31(6):417-21.
57.    Sadeghi H, Soltani M, Kokhdan EP, Abbasi R, Sadeghi H, Mostafazade M, et al. Renoprotective effect of Otostegia persica on vancomycin-induced nephrotoxicity in rats. Comp Clin Pathol. 2021;30(16):431-439.
58.    Akbartabar Toori M, Joodi B, Sadeghi H, Sadeghi H, Jafari M, Talebianpoor MS, et al. Hepatoprotective activity of aerial parts of Otostegia persica against carbon tetrachloride-induced liver damage in rats. Avicenna J Phytomed. 2015 May-Jun;5(3):238-46. PMID: 26101757; PMCID: PMC4469958.
59.    Abasnezhad Z, Tehranipour M, Azafar Balanezhad S, Amintaheri N. The Effects of (Otostegia Persica) Hydroalcoholic Extract on VEGF Receptor Gene Expression Changes in the Angiogenesis in Chick Chorioalantoic Membrane. JSSU 2019; 27 (6) :1686-1700
60.    Umathe SN, Dixit PV, Vaghasiya JM, Jain NS. Influence of quercetin on diabetes-induced alteration in CYP3A activity and bioavailability of pioglitazone in rats. Am J Infect Dis. 2009;5(2):118-25.
61.    Gholamhoseinian A, Sharifi-Far F, Rahimi-Naiini M. Screening of methanol extracts of sixty plants from Kerman for their potential xanthine oxidase inhibitory activity. J HerbMed Pharmacol. 2017;6(3):126-9.
62.    Nazhvani AD, Razmkhah M, Jassbi A, Khademalizadeh M, Mahmoodi A. Evaluation of anticancer effect of Hibiscus sabdarifa, Otostegia persica, Otostegia aucheri, and Otostegia michauxii on oral squamous cell carcinoma cell line. J Dent Med (Tums). 2020;32(4):208-15.
63.    Mihaela I, Denisa M, Eva K, Constanta G, Pencea C, Vladica M, et al. Quercetin and epigallocatechin gallate effect on the lipid order parameter of peripheral blood mononuclear cells from diabetes patients. Rom Biotechnol Lett. 2009;14(6):4804-11.
64.    Yarahmadi A, Khademi F, Mostafavi-Pour Z, Zal F. In-Vitro Analysis of Glucose and Quercetin Effects on m-TOR and Nrf-2 Expression in HepG2 Cell Line (Diabetes and Cancer Connection). Nutr Cancer. 2018 Jul;70(5):770-775. doi: 10.1080/01635581.2018.1470654. Epub 2018 May 21. PMID: 29781726.
65.    Hedayati, Mahdiye, Pouraboli. The Effect of Methanolic Extract of Otostegia persica on Serum Glucose Level and Renal Function Indicators in Streptozotocin Induced Diabetic Rats. Zahedan J Res Med Sci. 2012 14(5):12-15.
66.    Tofighi Z, Ostad SN, Khezrrahdoost S, Salehizadeh H, Yassa N. Potent anti-nociceptive and anti-inflammatory effects of methanol fraction of Otostegia persica extract and its components. Res J Pharmacogn. 2017;4(2):23-9.
67.    Ebrahimpoor MR, Khaksar Z, Noorafshan A. Antidiabetic effect of Otostegia persica oral extract on streptozotocin-diabetic rats. Res J Biol Sci. 2009;4(12):1227-9.
68.    Ebrahimpoor MR, Khaksar Z, Noorafshan A. Anti-diabetic effect of orally administered Otostegia persica extract on streptozotocin diabetic rats. Comp Clin Pathol. 2011;20(5):523-5.
69.    Tofighi Z, Alipour F, Hadavinia H, Abdollahi M, Hadjiakhoondi A, Yassa N. Effective antidiabetic and antioxidant fractions of Otostegia persica extract and their constituents. Pharm Biol. 2014 Aug;52(8):961-6. doi: 10.3109/13880209.2013.874463. Epub 2014 Feb 20. PMID: 24555486.
70.    Ansari F, Shafaroodi H, Asgarpanah J. Anticonvulsant activity of Otostegia persica (Burm.) Boiss. Biosci Biotechnol Res Asia. 2014;11(2):733-7.
71.    Edremitlioǧlu M, Andiç MF, Sayin DB, Korkut O, Kisa Ü. Quercetin, a powerful antioxidant bioflavonoid, attenuates renal dysfunction in long-term experimental diabetes mellitus. Marmara Med J. 2011;24(2):88-99.
72.    Bostancıeri N, Elbe H, Eşrefoğlu M, Vardı N. Cardioprotective potential of melatonin, quercetin and resveratrol in an experimental model of diabetes. Biotech Histochem. 2022 Feb;97(2):152-157. doi: 10.1080/10520295.2021.1918766. Epub 2021 Apr 28. PMID: 33906539.
73.    Chis IC, Clichici A, Nagy AL, Oros A, Catoi C, Clichici S. Quercetin in association with moderate exercise training attenuates injuries induced by experimental diabetes in sciatic nerves. J Physiol Pharmacol. 2017 Dec;68(6):877-886. PMID: 29550800.
74.    Heidarinazhad S, Mahabady MK, Ranjbar R, Varzi HN, Mohammadian B, Tabandeh MR. Effect of maternal diabetes and quercetin exposure on the oxidative stress and kidney damage in rat’s fetus. Trop J Pharm Res. 2018;17(7):1325-30.
75.    Iskender H, Dokumacioglu E, Sen TM, Ince I, Kanbay Y, Saral S. The effect of hesperidin and quercetin on oxidative stress, NF-κB and SIRT1 levels in a STZ-induced experimental diabetes model. Biomed Pharmacother. 2017 Jun;90:500-508. doi: 10.1016/j.biopha.2017.03.102. Epub 2017 Apr 7. PMID: 28395272.
76.    Kim JH, Kang MJ, Choi HN, Jeong SM, Lee YM, Kim JI. Quercetin attenuates fasting and postprandial hyperglycemia in animal models of diabetes mellitus. Nutr Res Pract. 2011 Apr;5(2):107-11. doi: 10.4162/nrp.2011.5.2.107. Epub 2011 Apr 23. PMID: 21556223; PMCID: PMC3085798.
77.    Li D, Jiang C, Mei G, Zhao Y, Chen L, Liu J, et al. Quercetin Alleviates Ferroptosis of Pancreatic β Cells in Type 2 Diabetes. Nutrients. 2020 Sep 27;12(10):2954. doi: 10.3390/nu12102954. PMID: 32992479; PMCID: PMC7600916.
78.    Yao Z, Gu Y, Zhang Q, Liu L, Meng G, Wu H, et al. Estimated daily quercetin intake and association with the prevalence of type 2 diabetes mellitus in Chinese adults. Eur J Nutr. 2019 Mar;58(2):819-830. doi: 10.1007/s00394-018-1713-2. Epub 2018 May 12. PMID: 29754250.
79.    Zahedi M, Ghiasvand R, Feizi A, Asgari G, Darvish L. Does Quercetin Improve Cardiovascular Risk factors and Inflammatory Biomarkers in Women with Type 2 Diabetes: A Double-blind Randomized Controlled Clinical Trial. Int J Prev Med. 2013 Jul;4(7):777-85. 
Trends in Pharmaceutical Sciences and Technologies
Volume 11, Issue 2
June 2025
Pages 91-108

Files

Share

How to cite

Statistics